Effects of Somatostatin on Liver in ADPKD

NCT02119052 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease

Interventions

DRUG: octeotride
DRUG: placebo

Sponsor

Federico II University